Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Runge

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivoM S Runge, C Bode, G R Matsueda, et al.
Clinical Cardiology|April 14, 2000
High-output heart failure resulting from a remote traumatic aorto-caval fistula: diagnosis by echocardiographyG Abreo, D J Lenihan, P Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Role of reactive oxygen species in angiotensin ii signaling : the plot thickensG A Stouffer, C Patterson, N Madamanchi, et al.
Biochemistry|February 23, 1988
Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitroM S Runge, C Bode, G R Matsueda, et al.
Journal of the American College of Cardiology|October 16, 1999
Antioxidant vitamins: sorting out the good and the not so goodC Patterson, S Ballinger, G A Stouffer, et al.
Clinical Research|September 1, 1988
Increasing selectivity of plasminogen activators with antibodiesM S Runge, T Quertermous, G R Matsueda, et al.
Transactions of the Association of American Physicians|January 1, 1987
Antibody-enhanced thrombolysis: capture of tissue plasminogen activator by a bispecific antibody and direct targeting by an antifibrin-tissue plasminogen activator conjugate in vivoM S Runge, C Bode, G R Matsueda, et al.
Biotechniques|June 13, 1998
High-voltage and high-salt buffer facilitates electroporation of human aortic smooth-muscle cellsC N Yan, F Li, C Patterson, et al.
Science (New York, N.Y.)|January 6, 1989
Innovative approaches to plasminogen activator therapyE Haber, T Quertermous, G R Matsueda, et al.
Methods in Enzymology|January 1, 1989
Recombinant antibodies possessing novel effector functionsT W Love, M S Runge, E Haber, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivoM S Runge, C Bode, G R Matsueda, et al.
Clinical Cardiology|April 14, 2000
High-output heart failure resulting from a remote traumatic aorto-caval fistula: diagnosis by echocardiographyG Abreo, D J Lenihan, P Nguyen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Role of reactive oxygen species in angiotensin ii signaling : the plot thickensG A Stouffer, C Patterson, N Madamanchi, et al.
Biochemistry|February 23, 1988
Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitroM S Runge, C Bode, G R Matsueda, et al.
Journal of the American College of Cardiology|October 16, 1999
Antioxidant vitamins: sorting out the good and the not so goodC Patterson, S Ballinger, G A Stouffer, et al.
Clinical Research|September 1, 1988
Increasing selectivity of plasminogen activators with antibodiesM S Runge, T Quertermous, G R Matsueda, et al.
Transactions of the Association of American Physicians|January 1, 1987
Antibody-enhanced thrombolysis: capture of tissue plasminogen activator by a bispecific antibody and direct targeting by an antifibrin-tissue plasminogen activator conjugate in vivoM S Runge, C Bode, G R Matsueda, et al.
Biotechniques|June 13, 1998
High-voltage and high-salt buffer facilitates electroporation of human aortic smooth-muscle cellsC N Yan, F Li, C Patterson, et al.
Science (New York, N.Y.)|January 6, 1989
Innovative approaches to plasminogen activator therapyE Haber, T Quertermous, G R Matsueda, et al.
Methods in Enzymology|January 1, 1989
Recombinant antibodies possessing novel effector functionsT W Love, M S Runge, E Haber, et al.
Pageof 14